Pediatric patients and their families recently joined artist and designer Edin Rudic in creating a new interior wall design for the Food for Life program in the Mount Sinai Health System’s Clinic for Inherited Metabolic Diseases. Mr. Rudic donated his services to create the new design located in the reception area of the Medical Genetics Clinic. It incorporates a high-definition screen display of patient photos, and specially coated walls on which children can draw, adding fun to their hospital visits.
A long-standing belief that mammals use the same potent antiviral molecules deployed by plants and invertebrates is being challenged by researchers at Icahn School of Medicine at Mount Sinai.
Their findings, published in the July 10, 2014, issue of Cell Reports, surprised many scientists who assumed that antiviral RNA Interference (RNAi) exists in humans as a natural result of evolution.
Scientists know that human cells, like cells in every living organism with a nucleus, encode and generate small RNAs, which influence our genetics. It is also known that mammals combat viruses with interferons—proteins manufactured by immune cells in response to pathogens.
A young woman who underwent a high-stakes liver transplant at The Mount Sinai Hospital in May is now safely back home thanks to an extraordinary collaboration between Stephan Mayer, MD, Director of the Institute for Critical Care Medicine, and Sander Florman, MD, Charles Miller, MD, Professor of Surgery and Director of the Recanati/Miller Transplantation Institute, and their teams.
The New York State Department of Health, AIDS Institute has awarded the Institute for Advanced Medicine (IAM) at the Mount Sinai Health System, a five-year, $5 million clinical education and training grant to help health care providers in New York State improve the outcomes of patients with HIV, hepatitis C (HCV), and sexually transmitted diseases (STDs).
The Mount Sinai Hospital has been ranked No. 16 out of nearly 5,000 hospitals nationwide in the U.S. News & World Report 2014–15 “Best Hospitals” guidebook. Additionally, New York Eye and Ear Infirmary of Mount Sinai achieved a No. 10 national ranking for Ophthalmology, while Mount Sinai Beth Israel and Mount Sinai St. Luke’s/Mount Sinai Roosevelt attained “high-performing” designations in a total of 11 specialties.
Further, according to U.S. News & World Report, The Mount Sinai Hospital is one of only 17 hospitals to receive “very high scores” in at least six clinical specialties, earning it Honor Roll status.
The future of medicine, maintaining an edge in biomedical innovation, and the cost of health care in America were among the topics explored by Mount Sinai Health System leaders during the 2014 Aspen Ideas Festival, a yearly conclave that attracts several thousand policy makers, innovators, entrepreneurs, and executives who participate in thought-provoking discussions on health care and other major issues that impact America.
Kravis Children’s Hospital at Mount Sinai is nationally ranked in seven out of the ten pediatric specialties measured by U.S. News & World Report in its 2014-15 “Best Children’s Hospital” annual guidebook. Notably, for the first time, Kravis Children’s Hospital is ranked in neurology & neurosurgery, and neonatology.
The seven specialties are diabetes & endocrinology (No. 22), nephrology (No. 29), neurology & neurosurgery (No. 29), pulmonology (No. 30), gastroenterology & GI surgery (No. 40), neonatology (No. 49), and urology (No. 50). To develop the rankings, U.S. News & World Report surveyed 183 pediatric centers to obtain clinical data in each of the 10 specialties measured, and also asked 150 pediatric specialists in each specialty where they would refer their sickest patients.
The Mount Sinai Health System was highly represented in New York magazine’s recently released list of “Best Doctors in New York,” which named 227 physicians from all seven hospitals and 36 doctors from Mount Sinai’s affiliated hospitals. The 263 physicians represented 21 percent of the total 1,251 doctors on New York magazine’s 2014 list, which appeared online and in the June 9-15, 2014 print edition. The list covers physicians from throughout the New York metropolitan region, including Connecticut and New Jersey.
Erik Lium, PhD, an expert in academic-industry partnerships and commercializing early-stage scientific discoveries, has joined the Mount Sinai Health System as Vice President and Executive Director of Mount Sinai Innovation Partners (MSIP). In this role, Dr. Lium leads MSIP’s efforts to foster collaborative partnerships with pharmaceutical, medical device, diagnostic, and information technology companies, and to commercialize Mount Sinai discoveries.
Faculty from throughout the Mount Sinai Health System joined residents, and medical and graduate students, at a recent social event sponsored by Friends of Odysseus, a black male mentoring program established in 2012 at the behest of Mount Sinai leadership to assist with the recruitment, retention, and promotion of black and Hispanic males in the sciences and medicine.